The class of IFN-α14 activators, as outlined above, primarily consists of compounds that stimulate or modulate immune responses leading to the upregulation of type I interferons. These activators typically function through engaging various pattern recognition receptors (PRRs) like Toll-like receptors (TLRs), RIG-I-like receptors, or the cGAS-STING pathway. Activation of these pathways results in the transcriptional upregulation of type I interferons, including IFN-α14.
The activators range from synthetic analogs of microbial components, like Poly(I:C), CpG Oligodeoxynucleotides, and PAM3CSK4, to small molecule agonists like Resiquimod and Imiquimod. These compounds mimic the immunogenic components of pathogens, thereby triggering innate immune responses. This mimicry is essential for their function, as it ensures the activation of immune pathways without the presence of actual pathogens.Furthermore, compounds like 5'-Triphosphate RNA and 2'3'-cGAMP highlight the importance of intracellular signaling in the regulation of IFN-α14. They act as ligands for cytosolic sensors that detect viral components, leading to interferon production. Manganese (II) chloride's role in enhancing the sensitivity of the cGAS-STING pathway underscores the intricate regulation of innate immunity at the molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
A synthetic analog of double-stranded RNA (dsRNA), activating Toll-like receptor 3 (TLR3) and inducing type I interferons, including IFN-α14. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
An immune response modifier that activates Toll-like receptor 7 (TLR7), enhancing the production of type I interferons and potentially increasing IFN-α14 levels. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
A TLR7 agonist that stimulates the innate immune system, leading to the production of various cytokines, including type I interferons. | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $157.00 $282.00 $516.00 $1177.00 $20138.00 $32779.00 $70753.00 | 1 | |
A selective TLR7 agonist activating innate immune responses and potentially increasing type I interferon production. | ||||||
Pam3Cys-Ser-(Lys)4, Hydrochloride | 112208-00-1 | sc-507471 | 2 mg | $550.00 | ||
A synthetic triacylated lipopeptide mimicking bacterial lipopeptides, activating TLR1/2 and potentially influencing type I interferon production. | ||||||
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $31.00 | ||
Enhances the sensitivity of cGAS-STING pathway to cytosolic DNA, leading to increased production of type I interferons. | ||||||